Form 4: Ideaya Biosciences SVP, General Counsel Douglas B. Snyder Acquires 140,000 Stock Options

Douglas B. Snyder, SVP, General Counsel of Ideaya Biosciences, Inc., reported the acquisition of 140,000 stock options on September 26, 2024.

Summary

• On September 26, 2024, Douglas B. Snyder, the SVP, General Counsel of Ideaya Biosciences, Inc., acquired 140,000 stock options.
• The exercise price of these options is $30.50.
• The options vest over four years, starting with 25% vesting on the first anniversary of September 18, 2024, and the remainder vesting monthly thereafter.
• The expiration date for these options is September 25, 2034.
• Following the transaction, Snyder directly owns 140,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to stock option grants. The acquisition of stock options by an executive is generally viewed as a positive sign, but it's not a strong indicator of future performance.

Positives

• The acquisition of stock options by a high-ranking officer may indicate confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates stock options were granted to a key executive.

Stakeholder Impact

• The granting of stock options aligns the interests of the executive with those of the shareholders, potentially incentivizing value creation.

Key Dates